- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
Memorial Sloan Kettering Cancer CenterPfizerActive, not recruitingMetastatic Breast Cancer (MBC)United States
-
Merck KGaA, Darmstadt, GermanyCompletedBreast NeoplasmSpain, United Kingdom, Germany, Australia, Austria, Belgium, Israel, New Zealand, Portugal, Italy, Ireland
-
Memorial Sloan Kettering Cancer CenterBaruch College City University of New YorkActive, not recruitingBreast Cancer SurvivorsUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
Columbia UniversityAvon FoundationCompletedInvasive Breast CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Atossa Therapeutics, Inc.Quest Diagnostics-Nichols Insitute; National Reference Laboratory for Breast... and other collaboratorsCompletedBreast NeoplasmsUnited States
-
Joseph SparanoCompletedBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
BeiGeneActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Advanced Solid Tumor | Endometrial Cancer | GastroEsophageal Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast...Israel, United States, China, New Zealand, Australia
-
State University of New York - Upstate Medical...Completed
-
Hackensack Meridian HealthBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
Columbia UniversityActive, not recruitingTriple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareCompletedMetastatic HER2-Positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedHER2-Positive Early Stage Breast CancerUnited States
-
University of RochesterCompletedStress | Breast Feeding | Breast Milk ExpressionUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedLocally Advanced Breast CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedNewly Diagnosed Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI); Congressionally Directed Medical Research...RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Roswell Park Cancer InstituteRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast CarcinomaUnited States
-
Trustees of Dartmouth CollegeCompletedBreast Cancer ScreeningUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Enrolling by invitationBreast Cancer FemalesTaiwan
-
Roswell Park Cancer InstitutePfizerCompletedBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Columbia UniversityNational Cancer Institute (NCI); University of Wisconsin, Madison; National Institute...CompletedBreast Cancer RiskUnited States
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Ductal Breast Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast Carcinoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterGateway for Cancer ResearchRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Memorial Sloan Kettering Cancer CenterThe City College of New YorkRecruiting
-
PfizerCompletedAdvanced or Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Invasive Adenocarcinoma of the BreastUnited States
-
Rutgers, The State University of New JerseyRegeneron PharmaceuticalsRecruitingBreast Cancer | Breast Cancer Risk | Breast Cancer PreventionUnited States
-
Yale UniversityBristol-Myers SquibbRecruiting
-
University of RochesterWithdrawnHER2-positive Breast CancerUnited States
-
New Mexico Cancer Research AllianceActive, not recruitingHER2 Negative Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedLocally Advanced Breast CancerUnited States
-
National Cancer Institute (NCI)National Institutes of Health (NIH)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterCompleted
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
NSABP Foundation IncPfizerCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast CarcinomaUnited States